Welcome to Eisai India. 

Eisai (pronounced 'ā-zī’) is derived from the Japanese word for 'health product'​ and, here at Eisai, we discover, develop and market innovative, high quality medicines throughout the world. Eisai is one of the world's leading research-based pharmaceutical companies. With operations in the U.S., Asia, Europe, Russia, India, Africa, the Middle East, Australia and it's domestic home market of Japan, Eisai employs more than 11,000 people worldwide.
Eisai Pharmaceuticals India Pvt. Ltd. (Eisai India) was incorporated in October 2004, with registered office at Mumbai. Eisai Co.,Ltd was the first Japanese company to have a 100% subsidiary in Indian pharmaceutical market.
Eisai India product portfolio includes prescription medicines in several therapeutic areas such as central nervous system disorders, metastatic breast cancer, benign prostrate hyperplasia , muscle spasm, vertigo, gastrointestinal disorders, diabetes and peripheral neuropathy.

Eisai India has a dedicated team of well-trained 200 field force across the country under various specialties and more than 250 employees across Research and Manufacturing. We continuously work with Medical Doctors and the Healthcare professionals in India to ensure that they have updated information on our products so that they can prescribe the best products for the health care needs of their patients. 

Eisai India’s integrated Manufacturing and Research facility at Visakhapatnam (Vizag), Andhra Pradesh stimulates knowledge creation between teams – from those who create products through research, to those who produce - by bringing them together on one site and is supplemented by  the necessary support functions.

Eisai India’s Vizag facility manufactures Drug Substances (Active Pharmaceutical Ingredients-APIs), Drug Products (Oral solid dosage forms-Tablets) and carries out Developmental Research of Active Pharmaceutical Ingredients (APIs).This facility is registered as a pharmaceutical manufacturer at regulatory agencies viz USFDA, PMDA, MHRA and WHO. Research labs at Vizag facility are recognized by the Department of scientific and industrial research (DSIR). Facility also received the Certification of ISO 14001:2004 for Environment management system (EMS), OHSAS 18001 for Occupational Health and Safety Series and ISO 27001 for Information security management system from TUV SUD.

Pharmaceutical

Eisai Pharmaceuticals India

Dr. Sanjit Singh Lamba

Dr. Neeraj Kumar

Amit Mukherjee

Grc V.

Kalainidhi Tharmalingam

Joseph Kiran Kumar

Shubhangi N.

Sachin Vishwasrao

Suman Kumar

Hemant Nikam

Manoj Singh Chouhan

Dinesh Patil

Govindnath Jaiswar

Ghata Biswas

The Research and Development team at Eisai Pharmaceuticals India is responsible for discovering and developing innovative pharmaceutical products, focusing primarily on Active Pharmaceutical Ingredients (APIs) and oral solid dosage forms like tablets. Based out of the integrated Manufacturing and Research facility in Visakhapatnam, the team conducts extensive developmental research, ensuring compliance with regulatory standards such as USFDA, PMDA, MHRA, and WHO. This team plays a crucial role in advancing Eisai's mission to provide high-quality, effective medicines across various therapeutic areas, from central nervous system disorders to diabetes and cancer.

Research and Development

Sales and Marketing

Human Resources

Research and Development

About

Team members

Other teams at Eisai Pharmaceuticals India

Sales and Marketing

Human Resources